Where Will Rigetti Computing Stock Be in 5 Years?

Rigetti Computing has fallen 19% since the start of 2026 after hitting an all-time high of $56 in late 2025, as enthusiasm for quantum computing has faded. Fourth-quarter revenue declined 18% year over year to about $1.9 million, while operating losses widened 22% to $18.5 million and R&D spending was $17.3 million. The company still has $443.5 million in cash and short-term investments, but the article argues the stock faces dilution risk and is better avoided in favor of more diversified quantum exposure.

Analysis

The key market shift is not the deterioration of the quantum thesis; it is the collapse in willingness to fund pre-product optionality at elevated multiples. That matters because names like RGTIW are now in the part of the cycle where capital intensity is still rising but narrative support is fading, which raises the probability that future milestones get financed through dilution rather than rerating. The next leg down is more likely to be driven by funding overhang and investor fatigue than by a single bad quarter.

Second-order beneficiaries are the diversified platform names with adjacent compute monetization. GOOGL, NVDA, TSM, and AVGO can treat quantum as an R&D call option while preserving core earnings power, so any renewed quantum excitement is likely to route capital toward them first rather than into single-asset pure plays. That also means the market may increasingly value quantum as a strategic subsegment inside larger franchises, not as a standalone business model, compressing the odds of a sustained premium for independent developers.

The contrarian point is that the selloff may be early relative to the technology timeline: if commercialization is still years away, the right trade is not “buy the dip” but “own the toll collectors.” The biggest upside catalyst for RGTI would be non-dilutive government support or a credible enterprise contract that proves repeatable demand, while the biggest downside catalyst is a wider risk-off tape that forces investors to mark down long-duration science projects together. In the near term, sentiment can remain weak for weeks; over 6-18 months, fundamentals and balance-sheet durability should dominate.

Key Decisions for Investors

• Avoid initiating long exposure in RGTIW until there is evidence of non-dilutive funding or a step-up in backlog; the current setup offers asymmetric downside if the market re-rates the stock as a cash-burn story rather than a platform story.
• Add selectively to GOOGL on weakness as the cleaner quantum exposure; risk/reward is better because quantum is effectively free optionality inside a cash-generative core, with downside buffered if commercialization slips 2-3 years.
• Use a relative-value pair: long GOOGL / short RGTIW for 3-6 months. This captures the market’s likely preference for subsidized optionality over standalone dilution risk.
• Prefer NVDA, TSM, and AVGO as indirect beneficiaries over pure quantum names; if quantum sentiment improves, these names can absorb incremental hype without balance-sheet risk, while if it fades they remain anchored by core demand.
• If wanting convex exposure, consider call spreads on GOOGL or NVDA rather than outright long RGTIW; this limits decay while preserving upside if the market decides to reprice the entire innovation stack.